Reconstruction of orbital floor fracture with polyglactin 910/polydioxanon patch (ethisorb): a retrospective study.
OBJECTIVE
We sought to evaluate the effectiveness and the complications related to the use of Ethisorb (resorbable alloplastic material) in the reconstruction of orbital floor fractures.


METHODS
We retrospectively reviewed the charts of all patients who underwent orbital floor fracture reconstruction with Ethisorb since 2001. We only included patients with a minimum follow-up of 3 months. The following data were recorded for every patient: age, gender, cause of trauma, time from trauma to surgery, signs and symptoms, concomitant ocular injuries, radiographic analysis, pertinent intraoperative findings (including the type of approach), follow-up time, and postoperative complications.


RESULTS
Eighty-seven patients were included in the study. Twenty-one patients (24.1%) experienced postoperative complications. Of these, only 3 patients (3.4%) had permanent complications directly related to the Ethisorb membrane (diplopia, enophthalmos). Two of these patients required revision surgery and are discussed in the article.


CONCLUSIONS
The results of our study demonstrate the effectiveness of Ethisorb in the repair of small-to-moderate orbital floor fracture defects (up to a maximum size of 2 x 2 cm).
Büchel
Pascal
P
Department of Cranio-Maxillofacial, Skull Base, Facial Plastic and Reconstructive Surgery, Inselspital University of Berne, Switzerland.
Rahal
Akram
A
Seto
Ichiro
I
Iizuka
Tateyuki
T
D020341:Absorbable Implants; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018786:Bone Substitutes / Q000627:therapeutic use*; D002648:Child; D004172:Diplopia / Q000628:therapy; D015841:Enophthalmos / Q000601:surgery; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009915:Orbit / Q000601:surgery; D009917:Orbital Fractures / Q000601:surgery*; D016687:Polydioxanone / Q000627:therapeutic use*; D011091:Polyesters / Q000627:therapeutic use*; D011098:Polyglactin 910 / Q000627:therapeutic use*; D011100:Polyglycolic Acid / Q000627:therapeutic use*; D011183:Postoperative Complications; D019233:Retreatment; D012189:Retrospective Studies
D018786:Bone Substitutes; C460779:Ethisorb; D011091:Polyesters; D011100:Polyglycolic Acid; D016687:Polydioxanone; D011098:Polyglactin 910